Related Experiment Video
Updated: Jan 16, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Outcomes of patients undergoing elective DC cardioversion for atrial fibrillation: A district general hospital
A Abdullah1, G S Ramewal1, C Wright1
1The Dudley Group NHS Foundation Trust, Russells Hall Hospital, Dudley, UK.
Insights
Early DC cardioversion (DCCV) for atrial fibrillation (AF) is effective. Delays in DCCV at our institution were significant, impacting sinus rhythm maintenance. Amiodarone use post-DCCV improved long-term rhythm control.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Auditing
Background:
- Early DC cardioversion (DCCV) is effective for restoring sinus rhythm in atrial fibrillation (AF).
- This audit evaluated DCCV outcomes and predictors of sinus rhythm restoration at our institution.
- Significant delays in DCCV were observed, particularly when rate control was initiated first.
Purpose of the Study:
- To assess the outcomes of patients undergoing DCCV.
- To identify factors predicting successful restoration and maintenance of sinus rhythm post-DCCV.
- To evaluate the impact of treatment delays on DCCV success rates.
Main Methods:
- Retrospective audit of elective DCCV procedures performed in 2021.
- Inclusion of 243 patients with complete electronic case record data.
- Analysis of patient demographics, treatment delays, procedural success, and rhythm status at follow-up.
Main Results:
- Immediate DCCV success was 93.1%, with 91.5% maintaining sinus rhythm at discharge.
- Rhythm maintenance decreased to 48.6% at 6 months and 39.7% at one year.
- Fewer shocks and continued amiodarone use predicted better long-term sinus rhythm maintenance.
Conclusions:
- Elective DCCV should be considered early for AF management, avoiding prolonged rate control trials.
- Significant delays in DCCV at this institution impact long-term rhythm control.
- Amiodarone use post-DCCV is associated with improved one-year sinus rhythm maintenance.
Background:
DC cardioversion (DCCV), when performed early, effectively restores sinus rhythm in patients with atrial fibrillation (AF). This audit aimed to evaluate the outcomes of patients undergoing DCCV at our institution and assess the factors predicting restoration of sinus rhythm.
Methods:
This retrospective audit included patients who underwent elective DCCV in 2021 at our hospital. We excluded patients where data was incomplete. Data was collected from the electronic case records of the patients.
Results:
Two hundred forty-three patients (mean age 67.5±11.7 years, 67.1% male) were included in the analysis. The median delay from DCCV decision was 265 (108-826) days. Patients who were initially managed with rate control (158 (65%) patients) had longer DCCV wait times compared to those where DCCV was considered as the first line treatment (308 vs. 114 days, p<0.001). DCCV was immediately successful in 232 (93.1%) patients, with 226 (91.5%) maintaining sinus rhythm at discharge, 120 (48.6%) at 6 months and 98 (39.7%) at one year. Fewer shocks predicted sinus rhythm maintenance at discharge, 6 months, and one year (p<0.001). Amiodarone continued post-DCCV also predicted maintenance of sinus rhythm at one year (p=0.01). No significant differences were found in demographics, risk factors, DCCV delay, or LA size between those who maintained sinus rhythm and those who reverted to AF.
Conclusion:
At our institution, most patients experienced significant delays before elective cardioversion. Decision to perform DCCV should be taken early and not after an initial trial of rate control. In our patients, amiodarone helped maintain sinus rhythm after successful DCCV.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy II: Dilated Cardiomyopathy
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Cardiopulmonary Resuscitation III: AED Use

